Stock Analysis

iHuman Third Quarter 2024 Earnings: EPS: CN¥2.40 (vs CN¥0.98 in 3Q 2023)

NYSE:IH
Source: Shutterstock

iHuman (NYSE:IH) Third Quarter 2024 Results

Key Financial Results

  • Revenue: CN¥239.4m (down 8.4% from 3Q 2023).
  • Net income: CN¥25.1m (down 52% from 3Q 2023).
  • Profit margin: 11% (down from 20% in 3Q 2023). The decrease in margin was primarily driven by lower revenue.
  • EPS: CN¥2.40.
earnings-and-revenue-history
NYSE:IH Earnings and Revenue History December 27th 2024

All figures shown in the chart above are for the trailing 12 month (TTM) period

iHuman's share price is broadly unchanged from a week ago.

Risk Analysis

Before you take the next step you should know about the 2 warning signs for iHuman that we have uncovered.

Valuation is complex, but we're here to simplify it.

Discover if iHuman might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.

Access Free Analysis

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.